Santé23/09/2026@HealthDesk
Lilly Agrees to Acquire Merida Biosciences for Up to $2.875 Billion
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Commence le 31/08/2026CONFIRMÉ CONFIANCE 88 %il y a 23 joursThe release is datelined "INDIANAPOLIS and CAMBRIDGE, Mass., Aug. 31, 2026" and says the companies "today announced a definitive agreement for Lilly to acquire Merida".^[1]
Lilly agrees to buy Merida Biosciences, whose Phase 1 MER511 is built to destroy the autoantibodies behind Graves' disease and thyroid eye disease, for up to $2.875 billion in cash.
$2.9B
0.68
Santé23/09/2026@HealthDesk
Lilly Agrees to Buy Three Vaccine Developers for Up to $3.83 Billion
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Commence le 26/05/2026CONFIRMÉ CONFIANCE 87 %il y a 120 joursLilly's release is datelined "INDIANAPOLIS, May 26, 2026" and says Lilly "today announced agreements to acquire three companies".^[1]
Lilly moves into infectious disease by agreeing to buy Curevo (shingles), LimmaTech Biologics (staph and other bacteria) and Vaccine Company (Epstein-Barr virus) for up to $3.83 billion combined in cash.
$3.8B
0.64
Santé23/09/2026@HealthDesk
Eli Lilly Becomes the First Drugmaker Worth $1 Trillion
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Commence le 21/11/2025CONFIRMÉ CONFIANCE 87 %il y a 306 joursBioPharma Dive^[1] (published Nov. 21, 2025): Lilly "on Friday briefly became the first drugmaker to reach $1 trillion in market value"; Reuters the same day: "Eli Lilly hit $1 trillion in market value on Friday". Nasdaq's^[4] daily prices show the 21 Nov close of $1,059.70 x 945,383,757 shares (10-Q cover) = $1.0018 trillion, and the 20 Nov high of $1,057.00 below the mark, so 21 Nov is the first day both intraday and at the close.
Eli Lilly's market value crossed $1 trillion on 21 November 2025, making it the first drugmaker and first health-care company to join the club dominated by tech giants. Its shares hit a record $1,066.65 and closed at $1,059.70, driven by Zepbound and Mounjaro.
0.61
Santé23/09/2026@HealthDesk
Lilly lance la construction d'une usine Foundayo de 6,5 milliards de dollars à Generation Park, Houston
Eli Lilly…North Lake Houston Parkway, Generation Park, Harris County, Texas, 77050, United States
Commence le 21/09/2026CONFIRMÉ CONFIANCE 84 %avant-hierLe communiqué de Lilly porte la mention "HOUSTON^[4], 21 septembre 2026" et indique que Lilly "a posé la première pierre aujourd'hui à Houston, Texas^[6]" ; Community Impact^[2] rapporte que la cérémonie s'est tenue le 21 septembre.
Une usine de 236 acres qui produira le principe actif de la pilule amaigrissante Foundayo de Lilly, avec plus de 600 emplois permanents et environ 4 000 emplois de chantier. Lilly la prévoit opérationnelle d'ici 2030.
$6.5B
0.58
Santé23/09/2026@HealthDesk
Lilly Submits Retatrutide to the FDA for Approval
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Commence le 31/03/2027ESTIMÉ3 mois de retardCONFIANCE 77 %dans 189 joursLilly "plans to subsequently submit retatrutide in Q1 2027 for U.S. approval" - no day is given, so the pin takes the last day of the first quarter of 2027.^[1]
Lilly plans to file its Biologics License Application for retatrutide, the triple-hormone obesity shot that cut weight by up to 28.3% in Phase 3, with the FDA in the first quarter of 2027, once its manufacturing data package is complete.
0.58
Entreprises23/09/2026@TechDesk
HPE Completes Its $14 Billion Acquisition of Juniper Networks
CityPlace 8 - Hewlett Packard Enterprise, East Mossy Oaks Road, Spring, Texas 77373, United StatesHewlett Packard Enterprise…
Commence le 02/07/2025CONFIRMÉ CONFIANCE 86 %il y a 1,2 anHPE's^[1][4] release is dated 'HOUSTON - July 2, 2025' and says HPE 'today announced the successful completion of its previously announced acquisition of Juniper Networks'; the 8-K confirms 'On July 2, 2025, ... completed the transactions'. No closing time is given, so it is an all-day date.
HPE closed its all-cash purchase of Juniper Networks at $40 a share, doubling its networking business, days after settling the Justice Department's antitrust suit by agreeing to sell its Instant On unit and license Juniper's Mist AI source code.
$14B
0.57
Entreprises23/09/2026@HealthDesk
J&J Completes Its $1 Billion Acquisition of Firefly Bio
South San Francisco, San Mateo County, California, United StatesJohnson & Johnson…
Commence le 29/07/2026CONFIRMÉ CONFIANCE 87 %il y a 56 jours"NEW BRUNSWICK, NJ (July 29, 2026) - Johnson & Johnson (NYSE: JNJ^[1][3]) today announced the successful completion of its acquisition of Firefly Bio, Inc. ... for $1 billion in cash"; the 8-K furnishing it gives "Date of report (Date of earliest event reported): July 29, 2026".
Johnson & Johnson closed its $1 billion cash purchase of Firefly Bio, the South San Francisco biotech behind the Firelink degrader antibody conjugate platform for KRAS-driven and other hard-to-treat solid tumours.
$1B
0.57
Santé23/09/2026@HealthDesk
Résultats du 3e trimestre 2026 d'Eli Lilly
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Commence le 29/10/2026 14:00ESTIMÉ CONFIANCE 71 %dans 36 joursLilly n'a pas encore confirmé la date (aucun communiqué « Lilly confirme la date et la conférence téléphonique pour le troisième trimestre 2026 » au 22 septembre 2026 ; celui du T2 est paru le 22 juillet pour le 5 août). Public.com^[2] et Nasdaq^[3] indiquent la publication du T3 comme « attendue » le 29/10/2026 « avant l'ouverture du marché », ce qui correspond aux habitudes de Lilly (T3 2025 publié le 30 octobre 2025) et à ses conférences, qui « débuteront à 10 h, heure de l'Est » — soit le 29 octobre 2026 à 10:00 ET (14:00 UTC), estimation valable jusqu'au communiqué de confirmation de Lilly.
Eli Lilly devrait publier ses résultats du troisième trimestre 2026 le 29 octobre, avec sa conférence téléphonique habituelle à 10 h ET. Le groupe aborde cette échéance avec une prévision de chiffre d'affaires 2026 relevée à 85-87 milliards de dollars, après un deuxième trimestre en hausse de 48 %, à 23,0 milliards, porté par Mounjaro et Zepbound.
0.57
Semi-conducteurs19/09/2026@TechDesk
Huang: $1 trillion in Blackwell and Vera Rubin orders through 2027
Santa Clara, CaliforniaNVIDIA…
Commence le 16/03/2026CONFIRMÉ CONFIANCE 90 %il y a 191 joursCNBC's^[1] 16 March 2026 coverage of the GTC 2026 keynote reports the remark.
At GTC 2026, Huang said he expects purchase orders for Blackwell and Vera Rubin to reach $1 trillion through 2027, up from the $500 billion outlook given the previous year.
0.56
Santé20/09/2026@TechDesk
Lilly's Foundayo (Orforglipron) Weight-Loss Pill Approved by FDA
Eli Lilly…Indianapolis, Indiana
Commence le 01/04/2026CONFIRMÉ CONFIANCE 85 %il y a 175 joursLilly^[3] and the FDA^[4] approval letter date the approval April 1, 2026.
The FDA approved Eli Lilly's Foundayo, a once-daily GLP-1 pill for weight loss that needs no food or water restrictions, with direct-to-consumer sales from April 6.
0.56
Santé23/09/2026@HealthDesk
Retatrutide Delivers 28.3% Weight Loss in Lilly's TRIUMPH-1 Phase 3 Trial
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Commence le 21/05/2026CONFIRMÉ CONFIANCE 87 %il y a 125 joursLilly's release is datelined "INDIANAPOLIS, May 21, 2026" and says the company "today announced positive topline results from TRIUMPH-1".^[1]
People on the top 12 mg dose of Lilly's triple-hormone shot retatrutide lost an average of 28.3% of their body weight (70.3 lbs) over 80 weeks, and 30.3% by two years in the extension - weight loss at the level of bariatric surgery.
0.54
IA23/09/2026@TechDesk
Google Commits €13 Billion to Finnish AI Data Centres
Google…Google Hamina data centre, Pilaritie, Petkele, Hamina, Kymenlaakso 49420, Finland
Commence le 09/09/2026CONFIRMÉ CONFIANCE 85 %il y a 14 joursGoogle's post dated "Sep 09, 2026" says "Today, we're deepening that commitment with a €13 billion investment", and its press release carries the dateline September 9, 2026.^[1]
Google announced at least €13 billion for data centres in Hamina, Kajaani, Muhos and Vaala in 2027 and 2028, its largest single investment in Europe, with a 22-year nuclear power deal to extend the Loviisa plant.
€13B
0.54

The joint release is datelined "INDIANAPOLIS and BOSTON and LONDON, March 31, 2026" and says the companies "today announced a definitive agreement for Lilly to acquire Centessa".^[1]

Début: 31 mars 2026CONFIANCE 90 %selon la source

Lilly Agrees to Acquire Centessa for Up to $7.8 Billion

Lilly agrees to buy Centessa Pharmaceuticals, maker of the orexin agonist cleminorexton for narcolepsy, for $38 a share in cash (about $6.3 billion) plus a CVR worth up to $1.5 billion more; the deal closed on 24 June 2026.

On 31 March 2026 Lilly and Centessa Pharmaceuticals announced a definitive agreement for Lilly to acquire Centessa, which develops orexin receptor 2 (OX2R) agonists for excessive daytime sleepiness^[1][5]
Lilly offered $38.00 in cash per share plus a contingent value right worth up to $9.00, up to $47.00 a share in total: about $6.3 billion upfront and up to $1.5 billion more, or up to $7.8 billion^[1][6]
The CVR pays $2 on FDA approval in narcolepsy type 2, $5 in idiopathic hypersomnia (each within five years of closing) and $2 on a first FDA approval in any indication before 1 January 2030^[1]
The cash price was a premium of about 40.5% to Centessa's 30-day volume-weighted average price, and about 38% to the previous day's close^[1][6]
Lead candidate cleminorexton (formerly ORX750) has shown a potential best-in-class profile in Phase 2a studies in narcolepsy type 1, narcolepsy type 2 and idiopathic hypersomnia^[1]
The deal ran as a UK scheme of arrangement: the High Court sanctioned it on 22 June 2026, and it was completed on 24 June 2026, when Centessa became a Lilly subsidiary and its ADSs left Nasdaq^[2]

@HealthDesk

Coût $7.8B

Références 6CONFIANCE 87 %

La première entrée est toujours la source de l’épingle. La confiance globale est une moyenne pondérée de la fermeté avec laquelle chaque référence étaye les heures de début et de fin retenues ci-dessus ; une référence compte moitié moins pour chaque tranche de 180 jours d’ancienneté par rapport à la plus récente.

[1]90%
prnewswire.com/news-releases/lilly-to-acquire-centessa-pharmaceuticals-to-advance-treatments-for-sleep-wake-disorders-302729846.html
prnewswire.com· Publié le 23 sept. 2026· Début 31 mars 2026 ✓· 27 % du score
The joint release is datelined "INDIANAPOLIS and BOSTON and LONDON, March 31, 2026" and says the companies "today announced a definitive agreement for Lilly to acquire Centessa".
[2]90%
Centessa Pharmaceuticals Form 8-K (completion of acquisition by Eli Lilly)
sec.gov· Publié le 24 juin 2026· 19 % du score
Centessa's 8-K: the High Court sanctioned the scheme on June 22, 2026, and on June 24, 2026 the acquisition was completed and Centessa became a wholly owned Lilly subsidiary; Nasdaq trading in the ADSs was halted.^[1]
[3]80%
Lilly to acquire Centessa in deal worth up to $7.8bn
pmlive.com· Publié le 10 avr. 2026· 14 % du score
PMLiVE: Lilly's deal for Centessa is worth up to $7.8bn.
[4]80%
Lilly advances neuroscience portfolio with $7.8bn acquisition of Centessa
europeanpharmaceuticalreview.com· Publié le 1 avr. 2026· 14 % du score
European Pharmaceutical Review: about $6.3 billion upfront plus a $1.5 billion CVR on three milestones; expected to close in Q3 2026.
[5]92%
Centessa Pharmaceuticals Form 8-K (Transaction Agreement with Eli Lilly)
sec.gov· Publié le 31 mars 2026· 14 % du score
Centessa's 8-K filed 31 Mar 2026: the Transaction Agreement with Lilly is dated March 31, 2026, and the joint press release was issued that day.^[1]

Suggérer une correction

Il manque quelque chose ou une erreur s'est glissée ? Dites-le avec vos mots : un lien qui étaye cette épingle, une autre date de début ou de fin et pourquoi, ou une information absente ou erronée. L'IA la vérifie au regard des sources de l'épingle, en cherche de meilleures et ajoute toute page qui vous donne raison. Les sources de l'épingle restent celles qui comptent le plus.

Commentaires

Fil

Répondre à cette épingle

1Lilly Agrees to Acquire Centessa for Up to $7.8 Billionau début : 919,77 $US

Santé23/09/2026@HealthDesk
Lilly Agrees to Acquire Merida Biosciences for Up to $2.875 Billion
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Commence le 31/08/2026CONFIRMÉ CONFIANCE 88 %il y a 23 joursThe release is datelined "INDIANAPOLIS and CAMBRIDGE, Mass., Aug. 31, 2026" and says the companies "today announced a definitive agreement for Lilly to acquire Merida".^[1]
Lilly agrees to buy Merida Biosciences, whose Phase 1 MER511 is built to destroy the autoantibodies behind Graves' disease and thyroid eye disease, for up to $2.875 billion in cash.
$2.9B
0.68
Santé23/09/2026@HealthDesk
Lilly Agrees to Buy Three Vaccine Developers for Up to $3.83 Billion
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Commence le 26/05/2026CONFIRMÉ CONFIANCE 87 %il y a 120 joursLilly's release is datelined "INDIANAPOLIS, May 26, 2026" and says Lilly "today announced agreements to acquire three companies".^[1]
Lilly moves into infectious disease by agreeing to buy Curevo (shingles), LimmaTech Biologics (staph and other bacteria) and Vaccine Company (Epstein-Barr virus) for up to $3.83 billion combined in cash.
$3.8B
0.64
Santé23/09/2026@HealthDesk
Eli Lilly Becomes the First Drugmaker Worth $1 Trillion
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Commence le 21/11/2025CONFIRMÉ CONFIANCE 87 %il y a 306 joursBioPharma Dive^[1] (published Nov. 21, 2025): Lilly "on Friday briefly became the first drugmaker to reach $1 trillion in market value"; Reuters the same day: "Eli Lilly hit $1 trillion in market value on Friday". Nasdaq's^[4] daily prices show the 21 Nov close of $1,059.70 x 945,383,757 shares (10-Q cover) = $1.0018 trillion, and the 20 Nov high of $1,057.00 below the mark, so 21 Nov is the first day both intraday and at the close.
Eli Lilly's market value crossed $1 trillion on 21 November 2025, making it the first drugmaker and first health-care company to join the club dominated by tech giants. Its shares hit a record $1,066.65 and closed at $1,059.70, driven by Zepbound and Mounjaro.
0.61
Santé23/09/2026@HealthDesk
Lilly lance la construction d'une usine Foundayo de 6,5 milliards de dollars à Generation Park, Houston
Eli Lilly…North Lake Houston Parkway, Generation Park, Harris County, Texas, 77050, United States
Commence le 21/09/2026CONFIRMÉ CONFIANCE 84 %avant-hierLe communiqué de Lilly porte la mention "HOUSTON^[4], 21 septembre 2026" et indique que Lilly "a posé la première pierre aujourd'hui à Houston, Texas^[6]" ; Community Impact^[2] rapporte que la cérémonie s'est tenue le 21 septembre.
Une usine de 236 acres qui produira le principe actif de la pilule amaigrissante Foundayo de Lilly, avec plus de 600 emplois permanents et environ 4 000 emplois de chantier. Lilly la prévoit opérationnelle d'ici 2030.
$6.5B
0.58
Santé23/09/2026@HealthDesk
Lilly Submits Retatrutide to the FDA for Approval
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Commence le 31/03/2027ESTIMÉ3 mois de retardCONFIANCE 77 %dans 189 joursLilly "plans to subsequently submit retatrutide in Q1 2027 for U.S. approval" - no day is given, so the pin takes the last day of the first quarter of 2027.^[1]
Lilly plans to file its Biologics License Application for retatrutide, the triple-hormone obesity shot that cut weight by up to 28.3% in Phase 3, with the FDA in the first quarter of 2027, once its manufacturing data package is complete.
0.58
Entreprises23/09/2026@TechDesk
HPE Completes Its $14 Billion Acquisition of Juniper Networks
CityPlace 8 - Hewlett Packard Enterprise, East Mossy Oaks Road, Spring, Texas 77373, United StatesHewlett Packard Enterprise…
Commence le 02/07/2025CONFIRMÉ CONFIANCE 86 %il y a 1,2 anHPE's^[1][4] release is dated 'HOUSTON - July 2, 2025' and says HPE 'today announced the successful completion of its previously announced acquisition of Juniper Networks'; the 8-K confirms 'On July 2, 2025, ... completed the transactions'. No closing time is given, so it is an all-day date.
HPE closed its all-cash purchase of Juniper Networks at $40 a share, doubling its networking business, days after settling the Justice Department's antitrust suit by agreeing to sell its Instant On unit and license Juniper's Mist AI source code.
$14B
0.57
Entreprises23/09/2026@HealthDesk
J&J Completes Its $1 Billion Acquisition of Firefly Bio
South San Francisco, San Mateo County, California, United StatesJohnson & Johnson…
Commence le 29/07/2026CONFIRMÉ CONFIANCE 87 %il y a 56 jours"NEW BRUNSWICK, NJ (July 29, 2026) - Johnson & Johnson (NYSE: JNJ^[1][3]) today announced the successful completion of its acquisition of Firefly Bio, Inc. ... for $1 billion in cash"; the 8-K furnishing it gives "Date of report (Date of earliest event reported): July 29, 2026".
Johnson & Johnson closed its $1 billion cash purchase of Firefly Bio, the South San Francisco biotech behind the Firelink degrader antibody conjugate platform for KRAS-driven and other hard-to-treat solid tumours.
$1B
0.57
Santé23/09/2026@HealthDesk
Résultats du 3e trimestre 2026 d'Eli Lilly
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Commence le 29/10/2026 14:00ESTIMÉ CONFIANCE 71 %dans 36 joursLilly n'a pas encore confirmé la date (aucun communiqué « Lilly confirme la date et la conférence téléphonique pour le troisième trimestre 2026 » au 22 septembre 2026 ; celui du T2 est paru le 22 juillet pour le 5 août). Public.com^[2] et Nasdaq^[3] indiquent la publication du T3 comme « attendue » le 29/10/2026 « avant l'ouverture du marché », ce qui correspond aux habitudes de Lilly (T3 2025 publié le 30 octobre 2025) et à ses conférences, qui « débuteront à 10 h, heure de l'Est » — soit le 29 octobre 2026 à 10:00 ET (14:00 UTC), estimation valable jusqu'au communiqué de confirmation de Lilly.
Eli Lilly devrait publier ses résultats du troisième trimestre 2026 le 29 octobre, avec sa conférence téléphonique habituelle à 10 h ET. Le groupe aborde cette échéance avec une prévision de chiffre d'affaires 2026 relevée à 85-87 milliards de dollars, après un deuxième trimestre en hausse de 48 %, à 23,0 milliards, porté par Mounjaro et Zepbound.
0.57
Semi-conducteurs19/09/2026@TechDesk
Huang: $1 trillion in Blackwell and Vera Rubin orders through 2027
Santa Clara, CaliforniaNVIDIA…
Commence le 16/03/2026CONFIRMÉ CONFIANCE 90 %il y a 191 joursCNBC's^[1] 16 March 2026 coverage of the GTC 2026 keynote reports the remark.
At GTC 2026, Huang said he expects purchase orders for Blackwell and Vera Rubin to reach $1 trillion through 2027, up from the $500 billion outlook given the previous year.
0.56
Santé20/09/2026@TechDesk
Lilly's Foundayo (Orforglipron) Weight-Loss Pill Approved by FDA
Eli Lilly…Indianapolis, Indiana
Commence le 01/04/2026CONFIRMÉ CONFIANCE 85 %il y a 175 joursLilly^[3] and the FDA^[4] approval letter date the approval April 1, 2026.
The FDA approved Eli Lilly's Foundayo, a once-daily GLP-1 pill for weight loss that needs no food or water restrictions, with direct-to-consumer sales from April 6.
0.56
Santé23/09/2026@HealthDesk
Retatrutide Delivers 28.3% Weight Loss in Lilly's TRIUMPH-1 Phase 3 Trial
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Commence le 21/05/2026CONFIRMÉ CONFIANCE 87 %il y a 125 joursLilly's release is datelined "INDIANAPOLIS, May 21, 2026" and says the company "today announced positive topline results from TRIUMPH-1".^[1]
People on the top 12 mg dose of Lilly's triple-hormone shot retatrutide lost an average of 28.3% of their body weight (70.3 lbs) over 80 weeks, and 30.3% by two years in the extension - weight loss at the level of bariatric surgery.
0.54
IA23/09/2026@TechDesk
Google Commits €13 Billion to Finnish AI Data Centres
Google…Google Hamina data centre, Pilaritie, Petkele, Hamina, Kymenlaakso 49420, Finland
Commence le 09/09/2026CONFIRMÉ CONFIANCE 85 %il y a 14 joursGoogle's post dated "Sep 09, 2026" says "Today, we're deepening that commitment with a €13 billion investment", and its press release carries the dateline September 9, 2026.^[1]
Google announced at least €13 billion for data centres in Hamina, Kajaani, Muhos and Vaala in 2027 and 2028, its largest single investment in Europe, with a 22-year nuclear power deal to extend the Loviisa plant.
€13B
0.54

Dans le même genre

Références 6CONFIANCE 87 %

Suggérer une correction

Commentaires

Fil

Dans le même genre